Evidence map›Paper›PMID 20466132›Full record

ReviewMethods in cell biology2010

Methods in tubulin proteomics.

Leah M Miller, Hui Xiao, Berta Burd, Susan Band Horwitz, Ruth Hogue Angeletti, Pascal Verdier-Pinard

Abstract readReview
In one paragraph

Review in Methods in cell biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Smoking-Associated Carcinogen-Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 Activation.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Posttranslational modifications of the cytoskeleton.Cytoskeleton (Hoboken, N.J.) · 2021
    Review
  11. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Leah M MillerLaboratory of Macromolecular Analysis and Proteomics, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Hui Xiao
Berta Burd
Susan Band Horwitz
Ruth Hogue Angeletti
Pascal Verdier-Pinard
Albert Einstein College of Medicine · USInserm · FR

Funding

TAXOL--MECHANISMS OF ACTION AND RESISTANCER01CA077263 · NCI · YESHIVA UNIVERSITY · PI HORWITZ, SUSAN BAND, MCDAID, HAYLEY M. · 1998 to 2019
$7.8M
Proteomics of Hepatic CarcinogenesisR33CA101150 · NCI · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI ANGELETTI, RUTH HOGUE · 2004 to 2006
$1.9M
FT-ICR MASS SPECTROMETER: TYPE 1 DIABETESS10RR019891 · NCRR · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI ANGELETTI, RUTH HOGUE · 2004 to 2004
$1.7M
H/D Exchange Coupled to MS to Study Drug-Induced Change in Microtuble StructureR01CA124898 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI HORWITZ, SUSAN BAND · 2007 to 2010
$1.3M
MASS SPECTROMETER SYSTEM: OBESITYS10RR019352 · NCRR · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI ANGELETTI, RUTH HOGUE · 2004 to 2004
$379k
Defining the Tubulin Cytoskeleton of Drug Resistant Cells By High Resolution MSF32CA125923 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI MILLER, LEAH M. · 2007 to 2008
$84k
NCI NIH HHS CA077263NCI NIH HHS CA124898NCI NIH HHS CA125923NCI NIH HHS F32 CA125923NCI NIH HHS R01 CA077263NCI NIH HHS R01 CA124898NCI NIH HHS R33 CA101150NCI NIH HHS R33CA101150NCRR NIH HHS S10 RR019352NCRR NIH HHS S10 RR019891NIAID NIH HHS HHSN266200400054C
6 · The paper itself

Abstract

New analytical methods are needed for the successful outcome of experiments aimed at characterizing mechanisms of microtubule dynamics and at understanding the effects of drugs on microtubules. The identification of tubulin isotypes and of regions of the microtubule involved in drug interactions has been advanced by proteomic methodologies. The diversity of tubulin sequences and posttranslational modifications (PTMs) can generate a complex mixture of heterodimers with unique molecular dynamics driving specific functions. Mass spectrometry (MS)-based approaches have been developed, and in combination with chromatographic and/or electrophoretic separation of tubulin polypeptides or peptides, they have contributed to our understanding of tubulin proteomics. We present protocols that we have used for the analysis of tubulin isotypes and PTMs present in tubulin isolated from cells in culture or tissues and for the identification of tubulin regions altered by microtubule-stabilizing agents. Tubulin proteomics complements structural and computer modeling information for a high-resolution view of microtubule dynamics and its alteration by drugs. These methodologies will help in providing insights into tubulin isotype-specific functions and in the design of drugs targeting either all tubulin heterodimers indiscriminately or only those containing specific isotypes.

Indexed as

AnimalsCellsHumansMicrotubule ProteinsPharmaceutical PreparationsProtein BindingProtein IsoformsProtein Processing, Post-TranslationalProteomicsTissue ExtractsTubulinMicrotubule ProteinsPharmaceutical PreparationsProtein IsoformsTissue ExtractsTubulin

Identifiers

PMID20466132
PMCPMC4039033
OpenAlexW2122766760

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.